subject area of
- 5-(Perylen-3-yl)Ethynyl-arabino-Uridine (aUY11), an Arabino-Based Rigid Amphipathic Fusion Inhibitor, Targets Virion Envelope Lipids To Inhibit Fusion of Influenza Virus, Hepatitis C Virus, and Other Enveloped Viruses Academic Article
- A randomized study of alpha-interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders Academic Article
- Antibodies against Hepatitis C in a Population of Swedish Haemophiliacs and Heterosexual Partners Academic Article
- Biological and clinicopathological features associated with hepatitis C virus type 5 infections Academic Article
- Class A Scavenger Receptor–Mediated Double-Stranded RNA Internalization Is Independent of Innate Antiviral Signaling and Does Not Require Phosphatidylinositol 3-Kinase Activity Academic Article
- Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa-2a plus ribavirin Academic Article
- Co-Infection by Hepatitis C Virus in HIV-Infected Patients in Southern Brazil: Genotype Distribution and Clinical Correlates Academic Article
- Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada Academic Article
- Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis Academic Article
- Hepatitis C Virus-infected, HCV-RNA-negative Patients with Bleeding Disorders - Relationship to Age, HIV and Treatment Academic Article
- Hepatitis C genotypes in Australian haemophilia patients Academic Article
- Identification of numerous hepatitis C virus genotypes in Montreal, Canada. Academic Article
- Ledipasvir-Sofosbuvir Plus Ribavirin in Treatment-Naive Patients With Hepatitis C Virus Genotype 3 Infection: An Open-Label Study Academic Article
- Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon Academic Article
- Low levels of hepatitis C diagnosis and testing uptake among people who inject image and performance enhancing drugs in England and Wales, 2012-15 Academic Article
- Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection Academic Article
- Oral prostaglandin (PGE2) therapy for chronic viral hepatitis B and C Academic Article
- Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Academic Article
- Prevalence of hepatitis C infection in Hong Kong Academic Article
- Prevalence of insulin resistance in chronic hepatitis C genotype 1 and 3 patients Academic Article
- Proceedings of a consensus conference: Blood-borne HIV and hepatitis—Optimizing the donor selection process† Academic Article
- Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies Academic Article
- Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy. Academic Article
- Replication of Subgenomic Hepatitis C Virus Replicons in Mouse Fibroblasts Is Facilitated by Deletion of Interferon Regulatory Factor 3 and Expression of Liver-Specific MicroRNA 122 Academic Article
- Risk of cardiovascular disease associated with HCV and HBV co-infection among antiretroviral-treated HIV-infected individuals Academic Article
- Successful Lung Transplantation From Hepatitis C Positive Donor to Seronegative Recipient Academic Article
- Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection Academic Article
- Transmission of hepatitis C with pasteurised factor VIII Academic Article
- Treatment responses in Asians and Caucasians with chronic hepatitis C infection Academic Article
- UK consensus guidelines for the use of the protease inhibitors boceprevir and telaprevir in genotype 1 chronic hepatitis C infected patients Academic Article